329 | Humans |
189 | Female |
165 | Middle Aged |
165 | Aged |
147 | Male |
108 | Cost-Benefit Analysis |
99 | Adult |
95 | Computer Simulation |
79 | United States |
65 | Aged, 80 and over |
55 | Quality-Adjusted Life Years |
55 | Mass Screening |
50 | Models, Theoretical |
45 | Models, Statistical |
44 | Adolescent |
42 | Risk Factors |
41 | Models, Economic |
41 | Markov Chains |
37 | Age Factors |
36 | Health Care Costs |
35 | Sensitivity and Specificity |
30 | Risk Assessment |
29 | Models, Econometric |
29 | Incidence |
29 | Colorectal Neoplasms |
26 | Child |
25 | Treatment Outcome |
25 | Forecasting |
23 | Monte Carlo Method |
22 | Time Factors |
22 | Life Expectancy |
22 | Income |
22 | Breast Neoplasms |
21 | Health Policy |
21 | Early Detection of Cancer |
20 | Prevalence |
20 | Canada |
19 | Population Dynamics |
19 | Netherlands |
19 | Decision Support Techniques |
18 | Retirement |
18 | Quality of Life |
18 | Cohort Studies |
17 | Young Adult |
17 | HIV Infections |
17 | Demography |
16 | Survival Rate |
16 | Socioeconomic Factors |
16 | Social Security |
16 | Reproducibility of Results |
16 | Prognosis |
16 | Mammography |
16 | Disease Progression |
15 | Research |
15 | Models, Biological |
15 | Cost of Illness |
15 | Child, Preschool |
15 | Bone Density Conservation Agents |
15 | Animals |
14 | Software |
14 | Sex Factors |
14 | Osteoporosis |
14 | Infant |
14 | Health Expenditures |
14 | Family Characteristics |
14 | Drug Costs |
14 | Australia |
13 | Statistics as Topic |
13 | Population |
12 | Lung Neoplasms |
12 | Family |
12 | Decision Making |
12 | Colonoscopy |
11 | Uterine Cervical Neoplasms |
11 | Proportional Hazards Models |
11 | Probability |
11 | Outcome Assessment (Health Care) |
11 | Infant, Newborn |
11 | Heart Valve Prosthesis |
11 | Health Services Needs and Demand |
11 | Employment |
11 | Aortic Valve |
10 | Risk |
10 | Occult Blood |
10 | Insurance, Health |
10 | Insurance Coverage |
10 | Europe |
10 | Costs and Cost Analysis |
10 | Bioprosthesis |
9 | Survival Analysis |
9 | Smoking |
9 | Public Policy |
9 | National Health Programs |
9 | Medicare |
9 | Income Tax |
9 | Health Status |
9 | Follow-Up Studies |
9 | Fertility |
9 | Data Collection |
8 | Spain |
8 | Poverty |
8 | Population Surveillance |
8 | Mortality |
8 | Marriage |
8 | Health Benefit Plans, Employee |
8 | Fractures, Bone |
8 | Drug Therapy, Combination |
8 | Chronic Disease |
8 | Cardiovascular Diseases |
8 | Belgium |
8 | Anti-HIV Agents |
8 | Aging |
7 | Taxes |
7 | Salaries and Fringe Benefits |
7 | Regression Analysis |
7 | Randomized Controlled Trials as Topic |
7 | Prostatic Neoplasms |
7 | Prostate-Specific Antigen |
7 | Predictive Value of Tests |
7 | Policy Making |
7 | Physicians |
7 | Pensions |
7 | Patient Acceptance of Health Care |
7 | Papillomavirus Infections |
7 | Osteoporosis, Postmenopausal |
7 | Longitudinal Studies |
7 | Health Services Research |
7 | Health Services Accessibility |
7 | Great Britain |
7 | Evaluation Studies as Topic |
7 | Disabled Persons |
7 | Diabetes Mellitus, Type 2 |
7 | Delivery of Health Care |
7 | Cross-Sectional Studies |
7 | Algorithms |
6 | Stochastic Processes |
6 | Severity of Illness Index |
6 | Program Evaluation |
6 | Pregnancy |
6 | Neoplasm Staging |
6 | Myocardial Infarction |
6 | Models, Cardiovascular |
6 | Hospitalization |
6 | Heart Valve Prosthesis Implantation |
6 | Heart Valve Diseases |
6 | Health Planning |
6 | Financing, Personal |
6 | Emigration and Immigration |
6 | Eligibility Determination |
6 | Disease Outbreaks |
6 | Developing Countries |
6 | Developed Countries |
6 | Data Interpretation, Statistical |
6 | Cost Savings |
6 | Birth Rate |
6 | Antibodies, Monoclonal, Humanized |
6 | Alendronate |
6 | Age Distribution |
6 | Activities of Daily Living |
5 | Vaginal Smears |
5 | Stroke |
5 | South Africa |
5 | SEER Program |
5 | Retrospective Studies |
5 | Residence Characteristics |
5 | Research Design |
5 | Reoperation |
5 | Public Health |
5 | Patient Compliance |
5 | Papillomavirus Vaccines |
5 | Osteoporotic Fractures |
5 | Neoplasms |
5 | Models, Organizational |
5 | India |
5 | Health Surveys |
5 | Health Care Reform |
5 | France |
5 | Financing, Government |
5 | Feces |
5 | Family Planning Services |
5 | Cost Sharing |
5 | Colonography, Computed Tomographic |
5 | Antibodies, Monoclonal |
5 | Ambulatory Care |
5 | Adenoma |
5 | Acquired Immunodeficiency Syndrome |
4 | Urban Population |
4 | Tomography, X-Ray Computed |
4 | Specialization |
4 | Smoking Cessation |
4 | Sexual Behavior |
4 | Rural Population |
4 | Prosthesis Failure |
4 | Private Sector |
4 | Postoperative Complications |
4 | Population Growth |
4 | Pilot Projects |
4 | Patient Protection and Affordable Care Act |
4 | Onchocerciasis |
4 | Mental Disorders |
4 | Medically Uninsured |
4 | Logistic Models |
4 | Insurance, Pharmaceutical Services |
4 | Insect Vectors |
4 | Influenza, Human |
4 | Health Resources |
4 | Health Manpower |
4 | Genetic Predisposition to Disease |
4 | False Positive Reactions |
4 | Emigrants and Immigrants |
4 | Educational Status |
4 | Economics |
4 | Divorce |
4 | Disease-Free Survival |
4 | Diphosphonates |
4 | Diabetes Mellitus |
4 | Depression |
4 | Coronary Artery Bypass |
4 | Consumer Satisfaction |
4 | Confidence Intervals |
4 | Comparative Effectiveness Research |
4 | Clinical Trials as Topic |
4 | Case-Control Studies |
4 | Carcinoma, Non-Small-Cell Lung |
4 | California |
4 | Calibration |
4 | CD4 Lymphocyte Count |
4 | Antiretroviral Therapy, Highly Active |
4 | Albuminuria |
4 | Absorptiometry, Photon |
3 | Swine |
3 | Sweden |
3 | Stents |
3 | Social Environment |
3 | Small-Area Analysis |
3 | Sex Distribution |
3 | Ritonavir |
3 | Risk-Taking |
3 | Recurrence |
3 | Prosthesis Design |
3 | Practice Guidelines as Topic |
3 | Population Characteristics |
3 | Platelet Aggregation Inhibitors |
3 | Patient Selection |
3 | Palpation |
3 | Outcome and Process Assessment (Health Care) |
3 | Onchocerca volvulus |
3 | Obesity |
3 | Nursing Homes |
3 | Nova Scotia |
3 | Neoplasms, Radiation-Induced |
3 | Needs Assessment |
3 | Medicine |
3 | Medication Adherence |
3 | Medicaid |
3 | Marital Status |
3 | Lung Transplantation |
3 | Lung Diseases |
3 | Lopinavir |
3 | Longevity |
3 | Life Tables |
3 | Ivermectin |
3 | Ireland |
3 | Investments |
3 | Internationality |
3 | Homes for the Aged |
3 | Health Status Disparities |
3 | Health Behavior |
3 | HIV-1 |
3 | Government Regulation |
3 | Germany |
3 | Filaricides |
3 | Family Practice |
3 | Epidemiologic Methods |
3 | England |
3 | Empirical Research |
3 | Early Diagnosis |
3 | Dementia |
3 | Databases, Factual |
3 | Coronary Disease |
3 | Contraception Behavior |
3 | Continental Population Groups |
3 | Comorbidity |
3 | Communicable Disease Control |
3 | Commerce |
3 | Combined Modality Therapy |
3 | Cluster Analysis |
3 | Cervical Intraepithelial Neoplasia |
3 | Bone Density |
3 | Body Mass Index |
3 | Biopsy |
3 | Automatic Data Processing |
3 | Atrial Fibrillation |
3 | Asia |
3 | Antirheumatic Agents |
3 | Antineoplastic Agents |
3 | Anticoagulants |
3 | Angioplasty, Balloon, Coronary |
3 | Adenocarcinoma |
2 | Wuchereria bancrofti |
2 | Workload |
2 | Widowhood |
2 | Warfarin |
2 | Waiting Lists |
2 | Vulnerable Populations |
2 | Visual Acuity |
2 | Vision Disorders |
2 | Vaccination |
2 | Utilization Review |
2 | Urban Health Services |
2 | Universal Coverage |
2 | United States Social Security Administration |
2 | Uganda |
2 | Triage |
2 | Tobacco Products |
2 | Tissue Plasminogen Activator |
2 | Tissue Donors |
2 | Ticlopidine |
2 | Thrombolytic Therapy |
2 | Thromboembolism |
2 | Thiophenes |
2 | Thailand |
2 | Teriparatide |
2 | Tamoxifen |
2 | Switzerland |
2 | Spinal Diseases |
2 | Social Welfare |
2 | Social Sciences |
2 | Simuliidae |
2 | Sepsis |
2 | Schistosomiasis |
2 | Rural Health |
2 | Rural Health Services |
2 | Risk Reduction Behavior |
2 | Reverse Transcriptase Inhibitors |
2 | Resource Allocation |
2 | Reproduction |
2 | Reimbursement Mechanisms |
2 | Referral and Consultation |
2 | Rectal Neoplasms |
2 | Receptors, Tumor Necrosis Factor |
2 | Radiation Dosage |
2 | Pyrimidines |
2 | Pyridines |
2 | Public Assistance |
2 | Prospective Studies |
2 | Preventive Health Services |
2 | Pneumonia, Bacterial |
2 | Pneumococcal Vaccines |
2 | Pneumococcal Infections |
2 | Piperazines |
2 | Patient Preference |
2 | Patient Care Team |
2 | Patient Care Planning |
2 | Patient Admission |
2 | Parity |
2 | Parents |
2 | Papillomaviridae |
2 | Papanicolaou Test |
2 | Ovarian Neoplasms |
2 | Organometallic Compounds |
2 | Ontario |
2 | Oligopeptides |
2 | Odds Ratio |
2 | Observer Variation |
2 | Nuclear Family |
2 | New Zealand |
2 | Neoplasm Grading |
2 | National Health Insurance, United States |
2 | Motivation |
2 | Mothers |
2 | Morbidity |
2 | Models, Psychological |
2 | Models, Genetic |
2 | Middle East |
2 | Microcomputers |
2 | Methods |
2 | Medical History Taking |
2 | Mathematics |
2 | Mass Vaccination |
2 | Marketing of Health Services |
2 | Magnetic Resonance Imaging |
2 | Long-Term Care |
2 | Liver Failure |
2 | Leprosy |
2 | Lactation |
2 | Kidney Diseases |
2 | Japan |
2 | Italy |
2 | Insurance Selection Bias |
2 | Influenza Vaccines |
2 | Influenza A Virus, H1N1 Subtype |
2 | Infertility |
2 | Immunochemistry |
2 | Illegitimacy |
2 | Hypoglycemic Agents |
2 | Hyperlipidemias |
2 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
2 | Human papillomavirus 18 |
2 | Human papillomavirus 16 |
2 | Hospitals |
2 | History, 21st Century |
2 | History, 20th Century |
2 | Healthcare Disparities |
2 | Health Status Indicators |
2 | Health Services for the Aged |
2 | Health Personnel |
2 | Health Care Surveys |
2 | Health Care Rationing |
2 | HIV Protease Inhibitors |
2 | Glucocorticoids |
2 | Glaucoma |
2 | Glaucoma, Open-Angle |
2 | Geriatric Assessment |
2 | Genes, BRCA1 |
2 | Frail Elderly |
2 | Finland |
2 | Fibrinolytic Agents |
2 | Fees and Charges |
2 | Feasibility Studies |
2 | Far East |
2 | Family Health |
2 | Evidence-Based Practice |
2 | Evidence-Based Medicine |
2 | European Continental Ancestry Group |
2 | Environment Design |
2 | Emergency Service, Hospital |
2 | Elephantiasis, Filarial |
2 | Electrocardiography |
2 | Efficiency, Organizational |
2 | Drug Utilization |
2 | Drug Resistance, Viral |
2 | Drug Prescriptions |
2 | Drug Administration Schedule |
2 | Disability Evaluation |
2 | Direct Service Costs |
2 | Diabetic Retinopathy |
2 | Diabetic Angiopathies |
2 | Deoxycytidine |
2 | Decision Support Systems, Clinical |
2 | Decision Making, Computer-Assisted |
2 | Databases as Topic |
2 | Cytological Techniques |
2 | Critical Care |
2 | Coronary Artery Disease |
2 | Coronary Angiography |
2 | Contraception |
2 | Contact Tracing |
2 | Clinical Trials, Phase III as Topic |
2 | Choice Behavior |
2 | China |
2 | Chest Pain |
2 | Censuses |
2 | Cause of Death |
2 | Cattle |
2 | Catheter Ablation |
2 | Carcinoma |
2 | Carcinoma, Small Cell |
2 | Breast Feeding |
2 | Blood Pressure |
2 | Bias (Epidemiology) |
2 | Benzamides |
2 | Back Pain |
2 | Automobile Driving |
2 | Aspirin |
2 | Arthritis |
2 | Arthritis, Rheumatoid |
2 | Aortic Valve Insufficiency |
2 | Antibodies, Monoclonal, Murine-Derived |
2 | Anti-Retroviral Agents |
2 | Amputation |
2 | Alzheimer Disease |
2 | African Americans |
2 | Africa |
2 | Africa, Western |
2 | Africa South of the Sahara |
2 | Acute Coronary Syndrome |
2 | Actuarial Analysis |
2 | Absenteeism |
1 | gamma-Aminobutyric Acid |
1 | beta-Alanine |
1 | alpha 1-Antitrypsin Deficiency |
1 | Workplace |
1 | Women, Working |
1 | Women's Health |
1 | Women's Health Services |
1 | Wet Macular Degeneration |
1 | Wales |
1 | Waist-Hip Ratio |
1 | Vitamin K 2 |
1 | Vitamin K 1 |
1 | Vital Statistics |
1 | Visually Impaired Persons |
1 | Visual Perception |
1 | Visual Fields |
1 | Vision Screening |
1 | Viral Tropism |
1 | Viral Load |
1 | Videotape Recording |
1 | Uterine Cervical Dysplasia |